Two Maine biotech companies have announced news regarding recent changes, Portland Press Herald reports. Scarborough based Fluid Imaging Technologies, BAM member and developer of a specialized device which allows for viewing particles in fluid, just introduced the expansion of their highly popular product, FlowCam, in the 50th country, giving the company a footprint in 7 continents. Shifting gears, another biotech startup company, Biovation of Boothbay is closing its doors. After seven years of developing and marketing innovative anti-microbial fiber products, the startup has laid off employees and put its assets up for sale. “With any risk comes the possibility of failure” said Biovation’s CEO Kerem Durdag about the recent development “It is my strongest belief that we as a state have to culturally get comfortable with the idea of risk if we are to be economically viable and have multiplier (effects) for our kids. And hence we have to see the value of failure. We just have to.” Read full article
Related Posts
Portland startup Marin Skincare launches lobster-based lip treatment
Portland startup Marin Skincare, known for its “lobster lotion,” is expanding that product line to include lip treatments. Founded out of the University...
UMaine scientists use eDNA to enhance river herring recovery research in Penobscot River
University of Maine researchers are seeking to gain more insight into river herring recovery in the Penobscot River using a novel...
FocusMaine co-founder named group’s next president
Nearly a decade after Andrea Cianchette Maker joined forces with Michael Dubyak to launch FocusMaine, Maker will lead the organization as...